Magnetic resonance imaging in progressive supranuclear palsy

Journal of Neurology

Volumn 258, Issue 4, 2011, Pages 549-558

  Stamelou, M ^a   Knake, S ^a   Oertel, W H ^a   Hoglinger G U ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Diffusion tensor imaging; Magnetic resonance imaging; Progressive supranuclear palsy; Proton magnetic resonance spectroscopy; Voxel based morphometry

Indexed keywords

AKINESIA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FRONTOTEMPORAL DEMENTIA; GAZE PARALYSIS; HUMAN; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; VOXEL BASED MORPHOMETRY;

BRAIN; BRAIN MAPPING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS; PROTONS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 79953832904     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5865-0     Document Type: Review

References (85)

1. Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1-9 (Pubitemid 26243849)
2. Burn DJ, Lees AJ (2002) Progressive supranuclear palsy: where are we now? Lancet Neurol 1:359-369
3. Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270-279
4. Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:6-15
5. Tsuboi Y, Slowinski J, Josephs KA et al (2003) Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 60:1766-1769 (Pubitemid 36737071)
6. Dickson D, Rademakers R, Hutton M (2007) Progressive supranuclear palsy: pathology and genetics. Brain Pathol 17:74-82
7. Osaki Y, Ben-Schlomo Y, Lees AJ et al (2004) Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 19:181-189 (Pubitemid 38312700)
8. Williams DR, de Silva R, Paviour DC et al (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128:1247-1258 (Pubitemid 40826179)
9. Williams DR, Holton JL, Strand K, Revesz T, Lees AJ (2007) Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 22:2235-2241
10. Tsuboi Y, Josephs KA, Boeve BF et al (2005) Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 20:982-988 (Pubitemid 41419514)
11. Josephs KA, Boeve BF, Duffy JR et al (2005) Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 11:283-296 (Pubitemid 41179599)
12. Josephs KA, Petersen RC, Knopman DS et al (2006) Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66:41-48 (Pubitemid 43739589)
13. Kaat LD, Boon AJ, Kamphorst W, Ravid R, Duivenvoorden HJ, van Swieten JC (2007) Frontal presentation in progressive supranuclear palsy. Neurology 69:723-729 (Pubitemid 47300928)
14. Ahmed Z, Josephs KA, Gonzalez J, DelleDonne A, Dickson DW (2008) Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 131:460-472 (Pubitemid 351197612)
15. Savoiardo M, Strada L, Girotti F et al (1989) MR imaging in progressive supranuclear palsy and Shy-Drager syndrome. J Comput Assist Tomogr 13:555-560 (Pubitemid 19183895)
16. Savoiardo M, Girotti F, Strada L, Ciceri E (1994) Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm 42:93-110 (Pubitemid 24212881)
17. Giménez-Roldán S, Mateo D, Benito C, Grandas F, Pérez-Gilabert Y (1994) Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. J Neural Transm Suppl 42:79-90
18. Yagishita A, Oda M (1996) Progressive supranuclear palsy: MRI and pathological findings. Neuroradiology 38:60-66
19. Soliveri P, Monza D, Paridi D et al (1999) Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 53:502-507 (Pubitemid 29382042)
20. Schulz JB, Skalej M, Wedekind D et al (1999) Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 45:65-74 (Pubitemid 29036434)
21. Kraft E, Schwarz J, Trenkwalder C, Vogl T, Pfluger T, Oertel WH (1999) The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol 56:225-228
22. Schrag A, Good CD, Miszkiel K et al (2000) Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 54:697-702 (Pubitemid 30082941)
23. Asato R, Akiguchi I, Masunaga S, Hashimoto N (2000) Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. J Neural Transm 107:1427-1436 (Pubitemid 32049938)
24. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L (2001) Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 58:1076-1079 (Pubitemid 32660770)
25. Yekhlef F, Ballan G, Macia F, Delmer O, Sourgen C, Tison F (2003) Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm 110:151-169 (Pubitemid 36216498)
26. Kato N, Arai K, Hattori T (2003) Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 210:57-60 (Pubitemid 36539405)
27. Righini A, Antonini A, De Notaris R et al (2004) MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 25:927-932 (Pubitemid 38765868)
28. Oba H, Yagishita A, Terada H et al (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64:2050-2055 (Pubitemid 40880991)
29. Cosottini M, Ceravolo R, Faggioni L et al (2007) Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 116:37-42 (Pubitemid 46976265)
30. Quattrone A, Nicoletti G, Messina D et al (2008) MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 246:214-221 (Pubitemid 350305046)
31. Hussl A, Mahlknecht P, Scherfler C et al (2010) Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy. Mov Disord 25:2444-2449
32. Adachi M, Kawanami T, Ohshima H, Sugai Y, Hosoya T (2004) Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci 3:125-132
33. Adachi M, Kawanami T, Ohshima F, Kato T (2006) Upper midbrain profile sign and cingulate sulcus sign: MRI findings on sagittal images in idiopathic normal-pressure hydrocephalus, Alzheimer's disease, and progressive supranuclear palsy. Radiat Med 24:568-572 (Pubitemid 351194463)
34. Mori H, Aoki S, Ohtomo K (2004) Morning glory sign is not prevalent in progressive supranuclear palsy. Magn Reson Med Sci 3:215
35. Paviour DC, Price SL, Stevens JM, Lees AJ, Fox NC (2005) Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 64:675-679 (Pubitemid 40261897)
36. Kataoka H, Tonomura Y, Taoka T, Ueno S (2008) Signal changes of superior cerebellar peduncle on fluid-attenuated inversion recovery in progressive supranuclear palsy. Parkinsonism Relat Disord 14:63-65
37. Slowinski J, Imamura A, Uitti RJ et al (2008) MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 255:37-44
38. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC (2006) Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 21:989-996
39. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 129:1040-1049
40. Cordato NJ, Pantelis C, Halliday GM et al (2002) Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 125:789-800 (Pubitemid 34279774)
41. Gröschel K, Hauser TK, Luft A et al (2004) Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 21:714-724 (Pubitemid 38229934)
42. Ashburner J, Friston KJ (2000) Voxel-based morphometry - the methods. Neuroimage 11:805-821 (Pubitemid 30437668)
43. Smith SM, Jenkinson M, Johansen-Berg H et al (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31:1487-1505
44. Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W (2004) Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 75:246-249 (Pubitemid 38183532)
45. Price S, Paviour D, Scahill R et al (2004) Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 23:663-669 (Pubitemid 39370617)
46. Boxer AL, Geschwind MD, Belfor N et al (2006) Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 63:81-86 (Pubitemid 43063865)
47. Josephs KA, Whitwell JL, Dickson DW et al (2008) Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 29:280-289
48. Seppi K, Poewe W (2010) Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin N Am 20:29-55
49. Le Bihan D (2003) Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 4:469-480
50. Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R (2006) Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics 26:205-223
51. Padovani A, Borroni B, Brambati SM et al (2006) Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 77:457-463
52. Nilsson C, Markenroth BK, Brockstedt S, Latt J, Widner H, Larsson EM (2007) Tracking the neurodegeneration of parkinsonian disorders - a pilot study. Neuroradiology 49:111-119 (Pubitemid 46218583)
53. Ito S, Makino T, Shirai W, Hattori T (2008) Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy. Neuroradiology 50:981-985
54. Erbetta A, Mandelli ML, Savoiardo M et al (2009) Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 30:1482-1487
55. Blain CR, Barker GJ, Jarosz JM et al (2006) Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology 67:2199-2205 (Pubitemid 46035477)
56. Nicoletti G, Tonon C, Lodi R et al (2007) Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord 23:2370-2376
57. Paviour DC, Price SL, Lees AJ, Fox NC (2007) MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. J Neurol 254:478-481 (Pubitemid 46786723)
58. Seppi K, Schocke MF, Esterhammer R et al (2003) Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology 60:922-927 (Pubitemid 36348922)
59. Rizzo G, Martinelli P, Manners D et al (2008) Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 131:2690-2700
60. Beaulieu C, Allen PS (1994) Determinants of anisotropic water diffusion in nerves. Magn Reson Med 31:394-400 (Pubitemid 24108269)
61. Glenn OA, Henry RG, Berman JI et al (2003) DTI-based three-dimensional tractography detects differences in the pyramidal tracts of infants and children with congenital hemiparesis. J Magn Reson Imaging 18:641-648 (Pubitemid 37467264)
62. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH (2003) Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20:1714-1722 (Pubitemid 37468277)
63. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH (2002) Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17:1429-1436 (Pubitemid 35333862)
64. Davis SW, Dennis NA, Buchler NG, White LE, Madden DJ, Cabeza R (2009) Assessing the effects of age on long white matter tracts using diffusion tensor tractography. Neuroimage 46:530-541
65. Knake S, Belke M, Menzler K et al (2010) In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord (Epub ahead of print)
66. Wolff SD, Balaban RS (1989) Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 10:135-144 (Pubitemid 19107973)
67. van Waesberghe JH, Kamphorst W, De Groot CJ et al (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46:747-754 (Pubitemid 29518136)
68. Hanyu H, Asano T, Sakurai H, Takasaki M, Shindo H, Abe K (2001) Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy. Neuroradiology 43:542-554
69. Eckert T, Sailer M, Kaufmann J et al (2004) Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 21:229-235 (Pubitemid 38115013)
70. Rango M, Bonifati C, Bresolin N (2006) Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study. J Cereb Blood Flow Metab 26:283-290 (Pubitemid 43151583)
71. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri MAA (2007) N-acetylaspartate in the CNS: from neurodiagnostics to Neurobiology. Prog Neurobiol 81:89-131 (Pubitemid 46282272)
72. Miller BL, Chang L, Booth R et al (1996) In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 58:1929-1935
73. Valenzuela MJ, Sachdev P (2001) Magnetic resonance spectroscopy in AD. Neurology 56:592-598 (Pubitemid 32209990)
74. Urenjak J, Williams SR, Gadian DG, Noble M (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981-989 (Pubitemid 23067586)
75. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO (1999) In vivo spectroscopic quantification of the N-acetyl moiety, creatine and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med 41:276-284
76. Federico F, Simone IL, Lucivero V et al (1997) Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 62:239-242 (Pubitemid 27117251)
77. Federico F, Simone IL, Lucivero V et al (1999) Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes. Italian J Neurol Sci 20:223-229
78. Tedeschi G, Litvan I, Bonatvita S et al (1997) Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 120:1541-1552
79. Abe K, Terakawa H, Takanashi M et al (2000) Proton magnetic resonance spectroscopy of patients with parkinsonism. Brain Res Bull 52:589-595
80. Stamelou M, Pilatus U, Reuss A et al (2009) In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy. J Cereb Blood Flow Metab 29:861-870
81. Pietz J, Rupp A, Ebinger F et al (2003) Cerebral energy metabolism in phenylketonuria: findings by quantitative in vivo 31P MR spectroscopy. Pediatr Res 53:654
82. Litvan I (2003) Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord 18:43-50
83. Agosta F, Kostić VS, Galantucci S et al (2010) The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study. Eur J Neurosci 32:640-647
84. Rohrer JD, Paviour D, Bronstein AM et al (2010) Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov Disord 25:179-188
85. Ridgway GR, Henley SM, Rohrer JD et al (2008) Ten simple rules for reporting voxel-based morphometry studies. Neuroimage 40:1429-1435